These include CPP 24, 43 and 44 cell lines that have been freshly established from primary tumour samples that express mutated KRAS, and the CTC44 and 45 cell lines derived from circulating tumour cells (CTC) [33,34]. The gene discussed is KRAS; the disease is neoplasm.